Deuterium
Products Related to Deuterium(604)
- GC49526Cytidine-d2CAS: 40632-25-5Purity: >99.00%
An internal standard for the quantification of cytidine
- GC49529Thymidine-d4CAS: 347841-67-2Purity: >99.00%
An internal standard for the quantification of thymidine
- GC49530Phenformin-d5 (hydrochloride)Purity: >99.00%
An internal standard for the quantification of phenformin
- GC495617-Methylguanosine-d3Purity: >99.00%
An internal standard for the quantification of 7-methylguanosine
- GC49564Carazolol-d7CAS: 1173021-02-7Purity: >99.00%
An internal standard for the quantification of carazolol
- GC49576Abnormal Cannabidiol-d3CAS: 2649096-15-9Purity: >99.00%
Internal standard for the quantification of abnormal cannabidiol
- GC49599N-Nitroso Desloratadine-d4CAS: 2733579-31-0Purity: >99.00%
An internal standard for the quantification of N-nitroso desloratadine
- GC49606Sertraline-d3 (hydrochloride)CAS: 1217741-83-7Purity: >99.00%
An internal standard for the quantification of sertraline
- GC4961121-Deoxycortisol-d8CAS: 2479914-04-8Purity: >99.00%
An internal standard for the quantification of 21-deoxycortisol
- GC49624Paroxetine-d6 (hydrochloride)Purity: >99.00%
An internal standard for the quantification of paroxetine
- GC49638Ambrisentan-d3CAS: 1189479-60-4Purity: >99.00%
An internal standard for the quantification of ambrisentan
- GC49648Enobosarm-d4CAS: 1202044-20-9Purity: >99.00%
An internal standard for the quantification of enobosarm
- GC49652Chlorpheniramine-d6 (maleate)CAS: 1219806-45-7Purity: >99.00%
An internal standard for the quantification of chlorpheniramine
- GC49662Ursocholic Acid-d4Purity: >99.00%
An internal standard for the quantification of ursocholic acid
- GC49677Olmesartan-d6CAS: 1185144-74-4Purity: >99.00%
An internal standard for the quantification of olmesartan
- GC49681Necrosulfonamide-d4CAS: 1795144-22-7Purity: >99.00%
Necrosulfonamide-d4는 Necrosulfonamide로 표시된 중수소입니다. Necrosulfonamide는 MLKL(mixed lineage kinase domain-like protein)을 선택적으로 표적화하여 작용하는 괴사 억제제입니다. Necrosulfonamide는 MLKL-RIP1-RIP3 necrosome 복합체가 다운스트림 이펙터와 상호 작용하는 것을 방지합니다. MLKL은 괴사 유도 동안 RIP3의 중요한 기질입니다.
- GC49682Dabigatran-d3CAS: 1246817-44-6Purity: >99.00%
An internal standard for the quantification of dabigatran
- GC49684Dabigatran-13C-d3CAS: 2967480-55-1Purity: >99.00%
An internal standard for the quantification of dabigatran
- GC49692Tofacitinib-d3 (citrate)Purity: >99.00%
An internal standard for the quantification of tofacitinib
- GC497301-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11Purity: >99.00%
An internal standard for the quantification of 1-stearoyl-2-15(S)-HETE- sn -glycero-3-PE
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49526 | Cytidine-d2 | 40632-25-5 | >99.00% | |
An internal standard for the quantification of cytidine | ||||
| GC49528 | Uridine-d2 | 40632-21-1 | >99.00% | |
우리딘-d2는 우리딘으로 표지된 중수소입니다. | ||||
| GC49529 | Thymidine-d4 | 347841-67-2 | >99.00% | |
An internal standard for the quantification of thymidine | ||||
| GC49530 | Phenformin-d5 (hydrochloride) | - | >99.00% | |
An internal standard for the quantification of phenformin | ||||
| GC49561 | 7-Methylguanosine-d3 | - | >99.00% | |
An internal standard for the quantification of 7-methylguanosine | ||||
| GC49564 | Carazolol-d7 | 1173021-02-7 | >99.00% | |
An internal standard for the quantification of carazolol | ||||
| GC49576 | Abnormal Cannabidiol-d3 | 2649096-15-9 | >99.00% | |
Internal standard for the quantification of abnormal cannabidiol | ||||
| GC49597 | Leukotriene B4-d5 | - | >99.00% | |
An internal standard for the quantification of LTB 4 | ||||
| GC49599 | N-Nitroso Desloratadine-d4 | 2733579-31-0 | >99.00% | |
An internal standard for the quantification of N-nitroso desloratadine | ||||
| GC49606 | Sertraline-d3 (hydrochloride) | 1217741-83-7 | >99.00% | |
An internal standard for the quantification of sertraline | ||||
| GC49611 | 21-Deoxycortisol-d8 | 2479914-04-8 | >99.00% | |
An internal standard for the quantification of 21-deoxycortisol | ||||
| GC49614 | Acenocoumarol-d4 | 2937878-24-3 | >99.00% | |
Acenocoumarol-d4는 Acenocoumarol로 표시된 중수소입니다. | ||||
| GC49624 | Paroxetine-d6 (hydrochloride) | - | >99.00% | |
An internal standard for the quantification of paroxetine | ||||
| GC49638 | Ambrisentan-d3 | 1189479-60-4 | >99.00% | |
An internal standard for the quantification of ambrisentan | ||||
| GC49648 | Enobosarm-d4 | 1202044-20-9 | >99.00% | |
An internal standard for the quantification of enobosarm | ||||
| GC49652 | Chlorpheniramine-d6 (maleate) | 1219806-45-7 | >99.00% | |
An internal standard for the quantification of chlorpheniramine | ||||
| GC49661 | Miltefosine-d4 | - | >99.00% | |
An internal standard for the quantification of miltefosine | ||||
| GC49662 | Ursocholic Acid-d4 | - | >99.00% | |
An internal standard for the quantification of ursocholic acid | ||||
| GC49677 | Olmesartan-d6 | 1185144-74-4 | >99.00% | |
An internal standard for the quantification of olmesartan | ||||
| GC49681 | Necrosulfonamide-d4 | 1795144-22-7 | >99.00% | |
Necrosulfonamide-d4는 Necrosulfonamide로 표시된 중수소입니다. Necrosulfonamide는 MLKL(mixed lineage kinase domain-like protein)을 선택적으로 표적화하여 작용하는 괴사 억제제입니다. Necrosulfonamide는 MLKL-RIP1-RIP3 necrosome 복합체가 다운스트림 이펙터와 상호 작용하는 것을 방지합니다. MLKL은 괴사 유도 동안 RIP3의 중요한 기질입니다. | ||||
| GC49682 | Dabigatran-d3 | 1246817-44-6 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49684 | Dabigatran-13C-d3 | 2967480-55-1 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49692 | Tofacitinib-d3 (citrate) | - | >99.00% | |
An internal standard for the quantification of tofacitinib | ||||
| GC49730 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 | - | >99.00% | |
An internal standard for the quantification of 1-stearoyl-2-15(S)-HETE- sn -glycero-3-PE | ||||
